Target intelligence / Profile preview

T cell receptor beta variable 7-6 (TRBV7-6)

Target
TRBV7-6
Molecular classification
Receptor, Immunoglobulin superfamily domain (variable region of TCR beta chain)
01

Overview

T cell receptor beta variable 7-6 (TRBV7-6) is a protein segment comprising the variable region of the beta chain of the T cell receptor (TCR), part of the immunoglobulin superfamily, expressed on the surface of T lymphocytes as a heterodimer with a TCR alpha chain[1][5]. The TCR beta variable region confers antigen specificity by binding peptide-major histocompatibility (MHC) complexes on antigen-presenting cells, initiating signaling cascades through CD3 and associated proteins to activate T cells and mediate adaptive immune responses[1][2][5]. TRBV7-6 is specifically generated by somatic V-(D)-J recombination during T cell development and contributes to the diversity and specificity of the T cell repertoire. While not directly addressed by current drugs, TCR beta variable regions, including TRBV7-6, are key components in the monitoring of immune responses and may serve as biomarkers or targets in immunotherapeutic applications, though their highly diverse nature limits direct drug targeting at present[1][5].

Other names
TRBV7-6TRBV76TCRBV6S3A1N1TTCRBV7S6V segment translation product
02

Biological functions

Antigen recognitionImmune responseSignal transduction
03

Disease associations

Cancer (as a component of tumor-infiltrating lymphocyte repertoire and immunotherapy relevance)Infection (pathogen-specific T cell responses)Other immune-related diseases (e.g., autoimmune disease through repertoire skewing)
04

Safety considerations

Risks of immune-related adverse events if engaged by therapies (on-target, off-tumor toxicity)Cross-reactivity leading to autoimmunity (common safety issue in TCR targeting therapies)
05

Biomarkers

T cell receptor repertoire sequencing (as immunotherapy/diagnostic biomarker in cancer and infection)

Beyond the preview

Go deeper on T cell receptor beta variable 7-6 (TRBV7-6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor beta variable 7-6 (TRBV7-6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call